Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (131-140 of 386) with videos related to

Pageof 39
Sort By:
Molecular Pharmacology|August 31, 2006
Dissecting the roles of checkpoint kinase 1/CDC2 and mitogen-activated protein kinase kinase 1/2/extracellular signal-regulated kinase 1/2 in relation to 7-hydroxystaurosporine-induced apoptosis in human multiple myeloma cellsXin-Yan Pei, Weiqun Li, Yun Dai, et al.
Oncogene|August 30, 2003
MAPK pathways in radiation responsesPaul Dent, Adly Yacoub, Paul B Fisher, et al.
Molecular Pharmacology|September 20, 2012
Lapatinib and obatoclax kill breast cancer cells through reactive oxygen species-dependent endoplasmic reticulum stressNichola Cruickshanks, Yong Tang, Laurence Booth, et al.
Blood|October 18, 2002
Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanismYun Dai, Terry H Landowski, Steven T Rosen, et al.
Cancer Biology & Therapy|August 7, 2013
PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cellsLaurence Booth, Nichola Cruickshanks, Thomas Ridder, et al.
Journal of Cellular Physiology|May 16, 2013
Sorafenib and HDAC inhibitors synergize with TRAIL to kill tumor cellsHossein A Hamed, Yukihiro Yamaguchi, Paul B Fisher, et al.
Blood|August 2, 2003
The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571Chunrong Yu, Mohamed Rahmani, Daniel Conrad, et al.
Molecular Cancer Therapeutics|March 16, 2005
Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathwaysMichael Hahn, Weiqun Li, Chunrong Yu, et al.
Leukemia Research|September 8, 2022
Functional role of DNMT1 in the anti-leukemic effects of hypomethylating agents in AML cellsLin Li, Xiaoyan Hu, Jewel Nkwocha, et al.
Statistical Methods in Medical Research|March 7, 2015
Experimental design and statistical analysis for three-drug combination studiesHong-Bin Fang, Xuerong Chen, Xin-Yan Pei, et al.
Pageof 39

Showing results (131-140 of 386) with videos related to

Sort By:
Pageof 39
Molecular Pharmacology|August 31, 2006
Dissecting the roles of checkpoint kinase 1/CDC2 and mitogen-activated protein kinase kinase 1/2/extracellular signal-regulated kinase 1/2 in relation to 7-hydroxystaurosporine-induced apoptosis in human multiple myeloma cellsXin-Yan Pei, Weiqun Li, Yun Dai, et al.
Oncogene|August 30, 2003
MAPK pathways in radiation responsesPaul Dent, Adly Yacoub, Paul B Fisher, et al.
Molecular Pharmacology|September 20, 2012
Lapatinib and obatoclax kill breast cancer cells through reactive oxygen species-dependent endoplasmic reticulum stressNichola Cruickshanks, Yong Tang, Laurence Booth, et al.
Blood|October 18, 2002
Combined treatment with the checkpoint abrogator UCN-01 and MEK1/2 inhibitors potently induces apoptosis in drug-sensitive and -resistant myeloma cells through an IL-6-independent mechanismYun Dai, Terry H Landowski, Steven T Rosen, et al.
Cancer Biology & Therapy|August 7, 2013
PARP and CHK inhibitors interact to cause DNA damage and cell death in mammary carcinoma cellsLaurence Booth, Nichola Cruickshanks, Thomas Ridder, et al.
Journal of Cellular Physiology|May 16, 2013
Sorafenib and HDAC inhibitors synergize with TRAIL to kill tumor cellsHossein A Hamed, Yukihiro Yamaguchi, Paul B Fisher, et al.
Blood|August 2, 2003
The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571Chunrong Yu, Mohamed Rahmani, Daniel Conrad, et al.
Molecular Cancer Therapeutics|March 16, 2005
Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathwaysMichael Hahn, Weiqun Li, Chunrong Yu, et al.
Leukemia Research|September 8, 2022
Functional role of DNMT1 in the anti-leukemic effects of hypomethylating agents in AML cellsLin Li, Xiaoyan Hu, Jewel Nkwocha, et al.
Statistical Methods in Medical Research|March 7, 2015
Experimental design and statistical analysis for three-drug combination studiesHong-Bin Fang, Xuerong Chen, Xin-Yan Pei, et al.
Pageof 39